Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/2000
03/15/2000EP0985047A2 Somatic gene therapy to suppress secondary cataract formation
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984956A1 Indoline derivatives as 5ht2c receptor antagonists
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984692A1 Novel angiogenesis inhibitors
03/15/2000EP0664802B1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
03/15/2000EP0533703B1 Use of steroids for the inhibition of angiogenesis
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247064A Compound urea drops for ear
03/15/2000CN1247063A Ear drops
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000CA2013188C Preservative system for ophthalmic formulations
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012488A1 Pyrazine compounds
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012130A1 Rp105 agonists and antagonists
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012098A1 Medicinal compositions for treating eye diseases
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012061A1 Synthetic tear fluid
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999038497A3 Ophthalmic composition
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342204A1 Medicinal compositions for treating eye diseases
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341543A1 Pyrazine compounds
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341409A1 Novel angiogenesis inhibitors
03/09/2000CA2340975A1 Synthetic tear fluid
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983084A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
03/08/2000EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246355A Medicinal composition for treating juvenile myopia
03/08/2000CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6033662 Oxygen activatable formulations for disinfection or sterilization
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010507A2 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000WO1999042088A3 Method for the treatment of diseases or disorders of the inner ear
03/02/2000WO1999011605A8 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/02/2000CA2341903A1 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/01/2000EP0982025A1 Synthetic tear fluid
03/01/2000EP0981534A2 Dinucleotides and their uses
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1246054A Use of green porphyrins for manufacture of medicament for treatment of secondary cataracts
03/01/2000CA2246791A1 Treatment of endothelium with somatostatin analogues
02/2000
02/29/2000US6031080 Chemotactic cytokine
02/29/2000US6030999 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
02/29/2000US6030612 Antimicrobial uses of multifunctional enzyme
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009512A2 Bipyridine manganese complexes
02/24/2000WO2000009503A1 Integrin receptor antagonists
02/24/2000WO2000009492A1 Tace inhibitors
02/24/2000WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/24/2000WO2000009484A1 Pipecolic acid derivatives and their use for vision and memory disorders
02/24/2000WO2000009479A2 Heterocyclic thioesters or ketones for vision and memory disorders
02/24/2000WO2000009162A1 Preventives/remedies for glaucoma
02/24/2000WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
02/24/2000WO2000009125A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders
02/24/2000WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders
02/24/2000WO2000009112A2 Heterocyclic esters or amides for vision and memory disorders
02/24/2000WO2000009110A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
02/24/2000WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders
02/24/2000WO2000009108A2 Compositions and uses for vision and memory disorders
02/24/2000WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders
02/24/2000WO2000009105A2 Small molecule carbamates or ureas for vision and memory disorders
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 531